Showing results (221-230 of 235) with videos related to

Sort By:
Pageof 24
Plos One|February 25, 2011
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectorsEsther D Quakkelaar, Anke Redeker, Elias K Haddad, et al.
Journal of Virology|February 14, 2020
Mechanisms of Endogenous HIV-1 Reactivation by Endocervical Epithelial CellsGermán G Gornalusse, Rogelio Valdez, Gabriella Fenkart, et al.
Plos Pathogens|June 27, 2020
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II TrialYves Lévy, Christine Lacabaratz, Kim Ellefsen-Lavoie, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Treponema pallidum periplasmic and membrane proteins are recognized by circulating and skin CD4+ T cellsTara B Reid, Charmie Godornes, Victoria L Campbell, et al.
The Journal of Infectious Diseases|June 27, 2024
Treponema pallidum Periplasmic and Membrane Proteins Are Recognized by Circulating and Skin CD4+ T CellsTara B Reid, Charmie Godornes, Victoria L Campbell, et al.
Open Forum Infectious Diseases|November 29, 2019
Trillions and Trillions: Herpes Simplex Virus-1 Hepatitis in an Immunocompetent AdultKevin Ikuta, Pavitra Roychoudhury, Hong Xie, et al.
Scientific Reports|February 23, 2021
In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19Isabelle Q Phan, Sandhya Subramanian, David Kim, et al.
The Journal of Clinical Investigation|December 15, 2020
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidatesJim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, et al.
Nature Communications|September 26, 2018
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLAK G Paulson, V Voillet, M S McAfee, et al.
Research Square|October 20, 2022
CD8+ T cell clonotypes from prior SARS-CoV-2 infection predominate during the cellular immune response to mRNA vaccinationEmily S Ford, Koshlan Mayer-Blackwell, Lichen Jing, et al.
Pageof 24